| Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak M Falcone, G Tiseo, A Antonelli, C Giordano, V Di Pilato, P Bertolucci, ... Open forum infectious diseases 7 (2), ofaa011, 2020 | 65 | 2020 |
| Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic … V Di Pilato, LH De Angelis, N Aiezza, I Baccani, C Niccolai, EM Parisio, ... The Lancet Microbe 3 (3), e224-e234, 2022 | 51 | 2022 |
| An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin A Cannatelli, T Giani, N Aiezza, V Di Pilato, L Principe, F Luzzaro, ... Scientific reports 7 (1), 5071, 2017 | 48 | 2017 |
| SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron A Mazzoni, A Vanni, M Spinicci, M Capone, G Lamacchia, L Salvati, ... Frontiers in Immunology 13, 801431, 2022 | 40 | 2022 |
| KPC-53, a KPC-3 variant of clinical origin associated with reduced susceptibility to ceftazidime-avibactam V Di Pilato, N Aiezza, V Viaggi, A Antonelli, L Principe, T Giani, F Luzzaro, ... Antimicrobial Agents and Chemotherapy 65 (1), 10.1128/aac. 01429-20, 2020 | 27 | 2020 |
| Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC … V Di Pilato, L Principe, L Andriani, N Aiezza, M Coppi, S Ricci, T Giani, ... Clinical Microbiology and Infection 29 (4), 537. e1-537. e8, 2023 | 23 | 2023 |
| Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens SR Boncompagni, M Micieli, T Di Maggio, N Aiezza, A Antonelli, T Giani, ... Journal of Antimicrobial Chemotherapy 77 (8), 2199-2208, 2022 | 15 | 2022 |
| Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy F Lagi, S Trevisan, M Piccica, L Graziani, G Basile, J Mencarini, B Borchi, ... International Journal of Infectious Diseases 108, 231-236, 2021 | 13 | 2021 |
| Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic … V Di Pilato, L Henrici De Angelis, N Aiezza, I Baccani, C Niccolai, ... DOI: https://doi. org/10.1016/S2666-5247 (21), 00268-8, 0 | 11 | |
| An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin. Sci Rep 7: 5071 A Cannatelli, T Giani, N Aiezza, V Di Pilato, L Principe, F Luzzaro, ... | 9 | 2017 |
| Rapid screening for SARS-CoV-2 VOC-alpha (202012/01, B. 1.1. 7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV assay N Giovacchini, M Coppi, N Aiezza, I Baccani, F Malentacchi, S Pollini, ... International Journal of Infectious Diseases 113, 207-209, 2021 | 8 | 2021 |
| Infective endocarditis associated with implantable cardiac device by metallo-β-lactamase-producing Pseudomonas aeruginosa, successfully treated with source control and … C Tascini, A Antonelli, M Pini, S De Vivo, N Aiezza, M Bernardo, ... Antimicrobial agents and chemotherapy 67 (3), e01313-22, 2023 | 6 | 2023 |
| SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including Omicron. Front Immunol 13: 801431 A Mazzoni, A Vanni, M Spinicci, M Capone, G Lamacchia, L Salvati, ... | 6 | 2022 |
| Up-regulation of resident chromosomal fosB gene expression: a novel mechanism of acquired fosfomycin resistance in MRSA N Aiezza, A Antonelli, M Coppi, V Di Pilato, T Giani, GM Rossolini Journal of Antimicrobial Chemotherapy 78 (7), 1599-1605, 2023 | 3 | 2023 |
| Activity of cefepime-taniborbactam (formerly cefepime/VNRX-5133) and comparators against NDM-producing Enterobacterales from a regional outbreak C Niccolai, A Antonelli, F Benvenuti, A Zenoni, N Aiezza, I Baccani, ... | 1 | |
| Evaluation of three commercial lateral flow immunoassays for the detection of KPC, VIM, NDM, IMP and OXA-48-like carbapenemases S Cuffari, N Aiezza, A Antonelli, T Giani, GM Rossolini Journal of Antimicrobial Chemotherapy, dkae262, 2024 | | 2024 |
| Associations of fosfomycin and colistin for use against biofilm-associated bacterial infections D Colombo, G Padoani, S Vailati, N Aiezza, A Antonelli, S Boncompagni, ... US Patent App. 18/548,670, 2024 | | 2024 |
| Evaluation of VITEK® 2 AST cards (AST-N376 and AST-N397) for susceptibility testing of challenging Gram negatives E Riccobono, N Aiezza, C Niccolai, T Giani, GM Rossolini Diagnostic Microbiology and Infectious Disease 107 (2), 116032, 2023 | | 2023 |
| Detection of emerging resistance mechanisms against old and novel last resort antimicrobials in Gram-negative and Gram-positive pathogens from low and high-income settings N Aiezza | | 2023 |
| Infective Endocarditis Associated with Implantable Cardiac Device by Metallo-b-Lactamase-Producing Pseudomonas aeruginosa, Successfully Treated with Source Control and … C Tascini, A Antonelli, M Pini, S De Vivo, N Aiezza, M Bernardo, ... | | 2023 |
